TB
Theravance Biopharma Inc (TBPH)
NASDAQ·Healthcare·Biotechnology
$17.03
+0.03%
Mkt Cap $884.19M
Analyst Ratings
Buy
1
Hold
5
Sell
0
Price Target (8 analysts)
$15.50
Range $14.00 – $17.00
Implied Upside
-9.0%
Consensus $15.50 vs current $17.03
NASDAQ·Healthcare·Biotechnology
$17.03
+0.03%
Mkt Cap $884.19M
Buy
1
Hold
5
Sell
0
Price Target (8 analysts)
$15.50
Range $14.00 – $17.00
-9.0%
Consensus $15.50 vs current $17.03